oxybutynin has been researched along with thiazoles in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aizawa, N; Homma, Y; Igawa, Y | 2 |
| Hatanaka, T; Kaku, S; Ohtake, A; Sato, S; Someya, A; Suzuki, M; Ueshima, K; Ukai, M; Watanabe, M | 1 |
| Bridgeman, MB; Dalal, KS | 1 |
| Kakizaki, H; Shimizu, N; Shimizu, T; Takai, S; Tyagi, P; Wada, N; Yoshimura, N | 1 |
| Antunes Lopes, T; Cornu, JN; Delongchamps, NB; Geavlete, B; Marcelissen, T; Rahnama'i, MS; Rashid, T; Rieken, M | 1 |
| Almeida, FG; Bernardo, WM; Sacomani, CAR; Silvinato, A | 1 |
| Hansson, F; Kilany, S; Milsom, I; Schiotz, HA; Svensson, M | 1 |
| Clodfelder-Miller, B; McNaught, J; Ness, TJ; Su, X | 1 |
| Furuhata, M; Hosaka, K; Ishizuka, O; Minagawa, T; Nakagawa, T; Ogawa, T; Saito, T; Suzuki, T | 1 |
| Ferreira, GM; Fraga, R; Jaworski, P; Mello, GF; Oliveira, MH | 1 |
| Ding, X; Li, X; Pan, Y; Pu, T; Sun, Y; Wang, Q; Yang, Y | 1 |
| He, Z; Jiang, Q; Liu, C; Ma, P; Sun, M; Sun, Y; Wang, J | 1 |
| Carrier, A; Chen, X; Chen, Y; Cui, S; Luan, T; Oakes, K; Singh, P; Yang, Y; Zeng, X; Zhang, X | 1 |
1 review(s) available for oxybutynin and thiazoles
| Article | Year |
|---|---|
Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?
Topics: Acetanilides; Administration, Oral; Adrenergic beta-3 Receptor Agonists; Aged; Case-Control Studies; Cholinergic Antagonists; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Compliance; Prevalence; Quality of Life; Thiazoles; Urinary Bladder, Overactive | 2019 |
2 trial(s) available for oxybutynin and thiazoles
| Article | Year |
|---|---|
Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial.
Topics: Acetanilides; Double-Blind Method; Female; Humans; Mandelic Acids; Nocturia; Quality of Life; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive | 2021 |
Mirabegron as effective as oxybutynin for ureteral stent symptoms.
Topics: Acetanilides; Humans; Mandelic Acids; Prospective Studies; Quality of Life; Stents; Surveys and Questionnaires; Thiazoles | 2021 |
12 other study(ies) available for oxybutynin and thiazoles
| Article | Year |
|---|---|
Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Female; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Thiazoles; Urinary Bladder | 2012 |
Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Wistar; Thiazoles; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Arginine; Electric Stimulation; Female; Mandelic Acids; Mechanotransduction, Cellular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neurons, Afferent; Nitric Oxide; Periodicity; Pressure; Rats, Sprague-Dawley; Reflex; Thiazoles; Time Factors; Urinary Bladder | 2015 |
New treatments for incontinence. Find out which of the latest therapies are worth trying.
Topics: Acetanilides; Botulinum Toxins, Type A; Humans; Mandelic Acids; Suburethral Slings; Thiazoles; Transdermal Patch; Urinary Incontinence; Urological Agents | 2014 |
Drugs for urologic disorders.
Topics: Acetanilides; Azasteroids; Drug Combinations; Dutasteride; Ferric Compounds; Gels; Humans; Injections; Maltose; Mandelic Acids; Sulfonamides; Tamsulosin; Thiazoles; Urologic Diseases; Urological Agents | 2015 |
Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Disease Models, Animal; Drug Therapy, Combination; Female; Mandelic Acids; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Thiazoles; Urinary Bladder; Urinary Bladder, Neurogenic; Urination; Urodynamics; Urological Agents | 2017 |
Overactive bladder - pharmacological treatment.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Antidepressive Agents; Benzilates; Benzofurans; Brazil; Clinical Decision-Making; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
A Nordic registry-based study of drug treatment patterns in overactive bladder patients.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Denmark; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Norway; Practice Patterns, Physicians'; Prospective Studies; Pyrrolidines; Registries; Solifenacin Succinate; Sweden; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
Medications used to treat bladder disorders may alter effects of neuromodulation.
Topics: Acetanilides; Animals; Cystitis; Electric Stimulation Therapy; Female; Mandelic Acids; Muscle Contraction; Pudendal Nerve; Rats; Rats, Sprague-Dawley; Thiazoles; Urological Agents | 2020 |
Pharmacokinetics and pharmacodynamics of glycyrrhetinic acid with Paeoniflorin after transdermal administration in dysmenorrhea model mice.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Synergism; Drugs, Chinese Herbal; Dysmenorrhea; Female; Glucosides; Glycyrrhetinic Acid; Meloxicam; Mice; Monoterpenes; Skin Absorption; Thiazines; Thiazoles; Tissue Distribution; Transdermal Patch | 2016 |
Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
Topics: Adhesives; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diethylamines; Drug Liberation; Male; Meloxicam; Muscles; Oleic Acid; Permeability; Rabbits; Rats, Sprague-Dawley; Skin; Skin Absorption; Skin Irritancy Tests; Thiazines; Thiazoles; Tissue Distribution; Transdermal Patch | 2018 |
Quantitation of polymeric-microneedle-delivered HA15 in tissues using liquid chromatography-tandem mass spectrometry.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Liberation; Female; Limit of Detection; Melanoma, Experimental; Mice; Mice, Nude; Needles; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry; Thiazoles; Tissue Distribution; Transdermal Patch | 2020 |